Ambev S.A. ABEV3.SA
BR · B3 (Brasil Bolsa) · XBSP · stock · Consumer Defensive · website
Ambev S.A. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $88.2B | $89.5B | $79.7B | $79.7B |
| Gross profit | $45.4B | $45.8B | $40.4B | $39.3B |
| SG&A expense | $25.1B | $26.4B | $23.4B | $24.0B |
| Operating income | $22.3B | $21.5B | $18.8B | $17.4B |
| Interest expense | $2.7B | $2.4B | $2.8B | $2.9B |
| Income tax | $3.4B | $4.6B | $75.5M | -$655.6M |
| Net income | $15.5B | $14.4B | $14.5B | $14.5B |
| EPS (diluted) | $0.93 | $0.91 | $0.92 | $0.93 |
| Operating cash flow | $24.5B | $26.1B | $24.7B | $20.6B |
| Free cash flow | $19.9B | $21.3B | $18.7B | $14.1B |
| Cash & equivalents | $18.6B | $28.6B | $16.1B | $14.9B |
| Inventory | $10.5B | $11.7B | $9.1B | $12.6B |
| Total assets | $145.1B | $162.5B | $132.6B | $138.0B |
| Total liabilities | $56.3B | $62.9B | $52.5B | $54.6B |
| Shareholders' equity | $87.9B | $98.6B | $79.0B | $82.0B |
Growth · year-over-year · Revenue CAGR 3.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.4% | +12.2% | +0.0% | — |
| Net income growth | +7.4% | -0.4% | +0.3% | — |
| EPS growth | +2.2% | -1.1% | -1.1% | — |
| Free cash flow growth | -7.0% | +14.1% | +32.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · BR · as of 2025-12-31. Figures in BRL; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.